Prelude Capital Management’s NextCure NXTC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,525	Closed	-$110K	–	1787
2021 Q4	$110K	Sell	1,525 -3,592	-70%	-$259K	﹤0.01%	1333
2021 Q3	$414K	Buy	+5,117	New	+$414K	0.01%	741
2020 Q4	–	Sell	-92	Closed	-$10K	–	1318
2020 Q3	$10K	Buy	+92	New	+$10K	﹤0.01%	1099